Retrospective analysis on the outcome of haploidentical HSCT with post-transplant cyclophoshamide as GVHD prophylaxis
Haploidentical HSCT with Post-Transplant High-Dose Cyclophosphamide in Children and Adolescents with High Risk Hematological Malignancies. A Retrospective Multicenter Study from the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)
CESARO, SIMONE;
2015-01-01
Abstract
Retrospective analysis on the outcome of haploidentical HSCT with post-transplant cyclophoshamide as GVHD prophylaxis
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
